Trials / Completed
CompletedNCT05600413
Citrulline Supplementation On Vascular Responsiveness and Function in Postmenopausal Women
L-Citrulline Supplementation to Improve Vascular Function and Responsiveness at Rest and During Exercise in Postmenopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Texas Tech University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The objective of this project is to provide evidence that L-Citrulline (L-CIT) supplementation can improve vascular function at rest and in response to exercise in postmenopausal women.
Detailed description
L-CIT is a non-essential amino acid that is a precursor to L-arginine, the substrate used to produce an important vasodilatory molecule called nitric oxide. The purpose of this study is to identify the effects of 6 grams of L-CIT for 4 weeks on vascular function (endothelial function, blood flow, muscle oxygenation, and blood pressure) at rest and in response to different stressors (cold pressor test, isometric and dynamic exercise).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | L-Citrulline | 4 weeks of L-Citrulline supplementation (6 grams/day) |
| DIETARY_SUPPLEMENT | Placebo | 4 weeks of Placebo (crystalline cellulose) |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2022-04-27
- Completion
- 2022-04-27
- First posted
- 2022-10-31
- Last updated
- 2022-10-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05600413. Inclusion in this directory is not an endorsement.